137 related articles for article (PubMed ID: 9777944)
1. Morphometric analysis of lymphatic and blood vessels in human chronic viral liver diseases.
Yamauchi Y; Michitaka K; Onji M
Am J Pathol; 1998 Oct; 153(4):1131-7. PubMed ID: 9777944
[TBL] [Abstract][Full Text] [Related]
2. Morphometric analysis of lymphatic vessels in primary biliary cirrhosis.
Yamauchi Y; Ikeda R; Michitaka K; Hiasa Y; Horiike N; Onji M
Hepatol Res; 2002 Oct; 24(2):107. PubMed ID: 12270739
[TBL] [Abstract][Full Text] [Related]
3. [An evaluation of the degree of the morphological activity and the stage of the process in patients with chronic liver diseases caused by coinfection with the hepatitis B, C and/or D viruses].
Siutkin VE; Lopatkina TN; Popova IV
Arkh Patol; 1998; 60(6):37-41. PubMed ID: 9949904
[TBL] [Abstract][Full Text] [Related]
4. [Computerized histological analysis in chronic viral hepatitis].
Hassan C; Tavani PD; Serafini B
Pathologica; 1999 Jun; 91(3):173-8. PubMed ID: 10536462
[TBL] [Abstract][Full Text] [Related]
5. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC
Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634
[TBL] [Abstract][Full Text] [Related]
6. Liver biopsy performance and histological findings among patients with chronic viral hepatitis: a Danish database study.
Christensen PB; Krarup HB; Møller A; Laursen AL; Kjaer MS; Orholm M; Lindberg J; Groenbaek K; Kromann-Andersen H; Weis N;
Scand J Infect Dis; 2007; 39(3):245-9. PubMed ID: 17366055
[TBL] [Abstract][Full Text] [Related]
7. The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis.
Xie SB; Yao JL; Zheng SS; Yao CL; Zheng RQ
Hepatobiliary Pancreat Dis Int; 2002 May; 1(2):202-6. PubMed ID: 14607739
[TBL] [Abstract][Full Text] [Related]
8. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
[TBL] [Abstract][Full Text] [Related]
9. Quantitative study of the topographic distribution of conjunctival lymphatic vessels in the monkey.
Guo W; Zhu Y; Yu PK; Yu X; Sun X; Cringle SJ; Su EN; Yu DY
Exp Eye Res; 2012 Jan; 94(1):90-7. PubMed ID: 22138558
[TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of liver fibrosis in patients with chronic hepatitis B].
Shi J; Hao JH; Ren WH; Zhu JR; Wang SY; Xie YB
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):443-5. PubMed ID: 19567024
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical comparative study of fibrosis and biliary ductular reaction in alcoholic and viral chronic hepatitis.
Egyed-Zsigmond I; Jung I; Egyed-Zsigmond I; Marton G; Gurzu S; Mezei T
Rom J Morphol Embryol; 2010; 51(2):265-9. PubMed ID: 20495741
[TBL] [Abstract][Full Text] [Related]
12. Replacement of hystological findings: serum hyaluronic acid for fibrosis, high-sensitive C-reactive protein for necroinflamation in chronic viral hepatitis.
Yilmaz S; Bayan K; Tüzün Y; Dursun M; Kaplan A; Ozmen S; Canoruç F; Akkuş Z
Int J Clin Pract; 2007 Mar; 61(3):438-43. PubMed ID: 17313611
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive models for predicting histology in patients with chronic hepatitis B.
Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of fibrosis in liver biopsies from patients with chronic hepatitis B.
Hui AY; Liew CT; Go MY; Chim AM; Chan HL; Leung NW; Sung JJ
Liver Int; 2004 Dec; 24(6):611-8. PubMed ID: 15566512
[TBL] [Abstract][Full Text] [Related]
16. Diabetes mellitus in chronic hepatitis B and C: prevalence and potential association with the extent of liver fibrosis.
Papatheodoridis GV; Chrysanthos N; Savvas S; Sevastianos V; Kafiri G; Petraki K; Manesis EK
J Viral Hepat; 2006 May; 13(5):303-10. PubMed ID: 16637860
[TBL] [Abstract][Full Text] [Related]
17. Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy.
Sakaida I; Nagatomi A; Hironaka K; Uchida K; Okita K
Am J Gastroenterol; 1999 Feb; 94(2):489-96. PubMed ID: 10022652
[TBL] [Abstract][Full Text] [Related]
18. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
19. [Assessment of disease activity and liver fibrosis in chronic viral hepatitis by magnetic resonance diffusion-weighted imaging].
Yang Y; Song B; Wu B; Lei XZ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):155-9. PubMed ID: 19507592
[TBL] [Abstract][Full Text] [Related]
20. Interferon gamma-secreting HCV-specific CD8+ T cells in the liver of patients with chronic C hepatitis: relation to liver fibrosis--ANRS HC EP07 study.
Bonilla N; Barget N; Andrieu M; Roulot D; Letoumelin P; Grando V; Trinchet JC; Ganne-Carrié N; Beaugrand M; Deny P; Choppin J; Guillet J; Ziol M
J Viral Hepat; 2006 Jul; 13(7):474-81. PubMed ID: 16792541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
